J & A Oben Foundation

The J & A Oben Foundation is a Cameroon-based research organization and biotechnology entity focused on the discovery and clinical validation of bioactive compounds for metabolic health. Founded by Professor Julius Oben, the foundation specializes in identifying phytochemicals from African medicinal plants that target obesity, type 2 diabetes, and metabolic syndrome. The foundation is globally recognized for developing proprietary ingredients such as IGOB131 (African Mango) and CQR-300 (Cissus quadrangularis), which have undergone rigorous human clinical trials to prove efficacy. These ingredients are licensed to international nutraceutical companies and are widely used in dietary supplements for weight management and glucose regulation. By bridging traditional African pharmacopeia with modern clinical science, the foundation serves as a key innovator in the global functional food and wellness industry.